Since the establishment of cannabis-complicit states in the US, there has been an overabundance of confusion regarding cannabis strains. This lack of clarity also led to a consumer who had difficulties finding a dispensary or seed bank.
Around the world, about 2.25 percent of the population uses cannabis. Most of them check a variety of items at Homegrown Cannabis Co. and grow them at home. States within the US are beginning cannabis programs one by one with little cooperation or standardization, but entire countries are doing so more efficiently at an equal pace.
There Are Different Kinds Of Cannabis Used For Medical And Recreational Purposes
Regardless of international policy, the world’s most leading nations have already implemented legal cannabis programs.
Cannabis is usually regulated as a drug in most of those countries. Israel in particular is even a minimum of ten years ahead of the US instituting basic regulatory standards within the production and extraction of cannabis for clinical trials resulting in patented products allowing entry into the promising market within the US.
In order to achieve market share for most US Cannabis providers, they have to play catch up. This all starts with defining a number of cannabis strains around the world that are being grown.
How well-established are cannabis laws in your state or are they constantly changing?
In October 2019, three new classes of cannabis were implemented in Canada, namely edible cannabis, cannabis extracts, and cannabis topicals, in order to establish a legal and regulatory framework for the production, distribution, sale and possession of marijuana. Even though no legislation is currently pending or proposed which would make any material change to the applicable statutes and regulations, given the relative infancy of the industry and the regulated regime.
The applicable regulations and laws are reasonably expected to continue to remain in place. Regulating one or more aspects of the industry may be subject to changes, refinements and/or updates in the future.
A Comprehensive Database Of Cannabis Strains
There has been a plethora of cannabis strains which have caused confusion, leading to a lack of transparency for purchasers. Around 39,000 strains of cannabis are grown within Washington state alone.
Furthermore, recreational cannabis consumers and patients are faced with the fact that most people measure flower value based on tetrahydrocannabinol (THC) content rather than taking everything off the pharmacologically active chem profile. In order to ease the growing uncertainty, both state regulators and cannabis testing laboratories should introduce broader chemical profiling, genotyping, and required cannabis cultivar registration with specific criteria required before cultivating the cultivar.
Moreover, quality assurance professionals in cannabis testing laboratories extend beyond just assessing cannabinoid potency. Furthermore, the laboratory has made available unique chemometrics and genotyping tools to de-mystify cannabis strains. Consumers are believed to benefit from both approaches because it enables them to be more confident in their purchases. However, findings indicate that they are willing to pay a premium for genotyped, authenticated flowers. Visit https://homegrowncannabisco.com/feminized-seeds for more products.
Most of the cannabis being grown within the US may be a Type I drug. It may be either indica or sativa seeds, containing CBD and THC.
Is It The Time For Green Waves From The East?
The Japanese government has approved the medical CBD brand Epidiolex for clinical trials, marking the first time the Japanese government has approved such products. Preparation for the clinical trials takes place in a hospital environment, exempt from Japan’s Cannabis Control Act, which prohibits cannabis compounds generally.
The U.S. Food and Drug Administration recently approved Epidiolex manufactured by UK-based GW Pharmaceutical. The Ministry of Health, Labor, and Welfare recently announced the trials with the Okinawa-Northern Task Force, a search and development agency.
Epidiolex was designed to treat two types of childhood epilepsy. It’s the first cannabis-derived prescription to achieve federal approval in the United States.
There are approximately 3,000 patients with Dravet Syndrome in Japan, and about 4,300 with Lennox-Gastaut.
Conclusion
To a casual observer, it is as if the cannabis industry has been on a wild roller coaster ride over the past two years, rocketing skyward only to slowly stalled or slowed down. As a result, we have witnessed a new global industry enjoying its first economic cycle.
Cannabis has been legalized in select US states followed by federal legalization in Canada and federal legalization of hemp cultivation in the United States in 2018, all of which have fueled the nascent industry. Capital from investors then poured in, providing the fuel for the company. Globally, licensed producers from Canada have rapidly expanded.
In addition to the United States, other nations have legalized cannabis in different ways. Even more investors became interested in cannabis-related activities. In 2011 there was a great deal of merger and acquisition (M&A) activity-despite incredibly high valuations. This decade has been marked by a great deal of capital, a need to scale, and an ambition for global expansion.
